相似文献
1
The promise and reality of cancer gene therapy.
Am J Hum Genet. 1997 Oct;61(4):785-9. doi: 10.1086/514898.
2
Cancer targeting using tumor suppressor genes.
Front Biosci. 2008 Jan 1;13:1959-67. doi: 10.2741/2815.
3
Gene replacement strategies for the prevention and therapy of cancer.
Eur J Cancer. 1994;30A(13):2032-7. doi: 10.1016/0959-8049(94)00398-o.
4
Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies.
J Natl Cancer Inst. 1996 Oct 16;88(20):1442-55. doi: 10.1093/jnci/88.20.1442.
5
Therapeutic targeting of tumor suppressor genes.
Cancer. 2015 May 1;121(9):1357-68. doi: 10.1002/cncr.29140. Epub 2014 Dec 29.
6
Learning how to suppress cancer.
Science. 1993 Sep 10;261(5127):1385-7. doi: 10.1126/science.8367721.
7
Importance of p53 for cancer onset and therapy.
Anticancer Drugs. 2006 Aug;17(7):725-32. doi: 10.1097/01.cad.0000217422.52208.fa.
8
Gene therapy of cancer.
Immunol Today. 1998 Jul;19(7):294-6. doi: 10.1016/s0167-5699(98)01280-8.
9
Therapeutic targeting of the p53 tumor suppressor gene.
Curr Opin Biotechnol. 1996 Dec;7(6):592-600. doi: 10.1016/s0958-1669(96)80069-3.
10
Modulation of oncogene and tumor-suppressor gene expression: a novel strategy for cancer prevention and treatment.
Ann Surg Oncol. 1994 Jan;1(1):79-86. doi: 10.1007/BF02303545.
本文引用的文献
1
Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene.
Clin Cancer Res. 1996 Jan;2(1):53-7.
2
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents.
Nat Med. 1997 Jun;3(6):639-45. doi: 10.1038/nm0697-639.
3
Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.
Cancer Gene Ther. 1997 Mar-Apr;4(2):91-6.
4
Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors.
Hum Gene Ther. 1997 Mar 1;8(4):477-88. doi: 10.1089/hum.1997.8.4-477.
5
Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma.
Hum Gene Ther. 1997 Feb 10;8(3):349-58. doi: 10.1089/hum.1997.8.3-349.
6
Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity.
Hum Gene Ther. 1997 Jan 20;8(2):177-85. doi: 10.1089/hum.1997.8.2-177.
7
In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene.
Cancer Res. 1997 Feb 1;57(3):461-5.
8
Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors.
Cancer Gene Ther. 1997 Jan-Feb;4(1):9-16.
9
Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12.
Hum Gene Ther. 1996 Oct 20;7(16):1995-2002. doi: 10.1089/hum.1996.7.16-1995.
10
Zotero 插件